Metraipolis › archive › dc_e22d665efd25

Comparative long-term outcomes of conventional immunomodulatory therapy, biologic agents, and combination therapy in chronic uveitis — Europe PMC PMID:42101763

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42101763
DOI
10.1186/s12348-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-02T15:53:22.473Z
SHA-256 of the archived text
b94f10ff38a12cedaf0ffc131137e403dd4b4e609edd593e0c519a85ec81b1f0
Stable URL of this page
https://metraipolis.com/documento/dc_e22d665efd25

How to cite

Comparative long-term outcomes of conventional immunomodulatory therapy, biologic agents, and combination therapy in chronic uveitis — Europe PMC PMID:42101763 — Europe PMC (en), https://europepmc.org/article/MED/42101763 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e22d665efd25 (Metraipolis archive dc_e22d665efd25, sha256 b94f10ff38a12cedaf0ffc131137e403dd4b4e609edd593e0c519a85ec81b1f0)
BibTeX
@misc{dce22d665efd25,
  title = {Comparative long-term outcomes of conventional immunomodulatory therapy, biologic agents, and combination therapy in chronic uveitis — Europe PMC PMID:42101763},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42101763},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e22d665efd25; sha256 b94f10ff38a12cedaf0ffc131137e403dd4b4e609edd593e0c519a85ec81b1f0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42101763. Agents can read the archived copy with the MCP tool read_document.